Association of low ficolin-lectin pathway parameters with Cardiac Syndrome X

Horváth, Zsófia and Csuka, Dorottya and Vargova, Katarina and Lee, S. and Varga, Lilian and Prohászka, Zoltán and Kiss, Róbert Gábor (2016) Association of low ficolin-lectin pathway parameters with Cardiac Syndrome X. Scandinavian Journal of Immunology, 84 (3). pp. 174-181. ISSN 0300-9475, ESSN: 1365-3083


Download (223kB) | Preview


In patients with typical angina pectoris, inducable myocardial ischaemia and macroscopically normal coronaries (Cardiac Syndrome X, CSX) significantly elevated plasma level of terminal complement complex (TCC), the common end-product of complement activation, has been observed without subsequent activation of the classical or the alternative pathways. Therefore, our aim was to clarify the role of the ficolin-lectin pathway in CSX. Eighteen CSX patients, 37 stable angina patients with significant coronary stenosis (CHD) and 54 healthy volunteers (HC) were enrolled. Serum levels of ficolin-2, ficolin-3, ficolin-3/MASP-2 complex and ficolin-3 mediated TCC deposition (FCN3-TCC) were determined. Plasma level of TCC was significantly higher in CSX than in HC or in CHD groups (5.45 vs. 1.30 vs. 2.04AU/ml, p<0.001). Serum levels of ficolin-2 and ficolin-3 were significantly lower in CSX compared to HC or to CHD groups (3.60 vs. 5.80 or 5.20mug/ml, p<0.05; 17.80 vs. 24.10 or 26.80mug/ml, p<0.05). The ficolin-3/MASP-2 complex was significantly lower in CSX group compared to HC (92.90 vs. 144.90AU/ml, p=0.006). FCN3-TCC deposition was significantly lower in the CSX group compared to HC and to CHD (67.8% vs.143.3% or 159.7%, p<0.05). In the CSX group, significant correlation was found between TCC and FCN3-TCC level (r=0.507, p=0.032) and ficolin-3/MASP-2 complex level and FCN3-TCC deposition (r=0.651, p=0.003). In conclusion, in patients with typical angina and myocardial ischemia despite macroscopically normal coronary arteries, low levels of several lectin-pathway parameters were observed, indicating complement activation and consumption. Complement activation through the ficolin-lectin pathway might play a role in the complex pathomechanism of CSX. This article is protected by copyright. All rights reserved.

Item Type: Article
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat
Depositing User: MTMT SWORD
Date Deposited: 25 Sep 2017 12:37
Last Modified: 25 Sep 2017 12:37

Actions (login required)

View Item View Item